PachavitKasemsapMDMBA, FACS

Summary

• Serving as senior medical director at Highmark, Inc., in Pittsburgh, Dr. Pachavit Kasemsap has oversight of contracted and employed physician groups spanning the country and serving more than 260,000 Medicare Advantage (MA) members. One of Pachavit Kasemsap, MD’s accomplishments has been achieving significant cost savings through the removal of five specialty drugs from Cancer Collaborative Pathway program's automatic authorization.
  
  Dr. Kasemsap has also set in place a step therapy process for treating macular degeneration that begins with Avastin, which costs significantly less than Lucentis and Eylea. He also created at new value-based reimbursement program, True Surplus Sharing. The program helped Highmark negotiate a contract with Geisinger Health and added numerous MA members to the Highmark portfolio via the Pennsylvania Employee Benefits Trust Fund.
  
  Pachavit Kasemsap, MD's background includes a past position with South Florida Surgical Specialists as surgeon, where he performed more than 1,350 operations from 2010 to 2012. A champion for the adoption of Computerized Physician Order Entry, he served on the Pharmacy and Therapeutics and Information Management committees.